BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Afsharian M, Saleki K, Barary M, Ebrahimpour S. Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients. Rev Med Virol 2021;:e2273. [PMID: 34197678 DOI: 10.1002/rmv.2273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Javanmehr N, Saleki K, Alijanizadeh P, Rezaei N. Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases. J Neuroinflammation 2022;19:273. [DOI: 10.1186/s12974-022-02637-1] [Reference Citation Analysis]
2 Mohseni Afshar Z, Sharma A, Babazadeh A, Alizadeh-khatir A, Sio TT, Taghizadeh Moghadam MA, Tavakolli Pirzaman A, Mojadad A, Hosseinzadeh R, Barary M, Ebrahimpour S. A review of the potential neurological adverse events of COVID-19 vaccines. Acta Neurol Belg 2022. [DOI: 10.1007/s13760-022-02137-2] [Reference Citation Analysis]
3 Mohseni Afshar Z, Tavakoli Pirzaman A, Liang JJ, Sharma A, Pirzadeh M, Babazadeh A, Hashemi E, Deravi N, Abdi S, Allahgholipour A, Hosseinzadeh R, Vaziri Z, Sio TT, Sullman MJM, Barary M, Ebrahimpour S. Do we miss rare adverse events induced by COVID-19 vaccination? Front Med (Lausanne) 2022;9:933914. [PMID: 36300183 DOI: 10.3389/fmed.2022.933914] [Reference Citation Analysis]
4 Saleki K, Shirzad M, Javanian M, Mohammadkhani S, Alijani MH, Miri N, Oladnabi M, Azadmehr A. Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients. Front Immunol 2022;13:947401. [DOI: 10.3389/fimmu.2022.947401] [Reference Citation Analysis]
5 Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. Aging, testosterone, and neuroplasticity: friend or foe? Rev Neurosci 2022. [PMID: 36017670 DOI: 10.1515/revneuro-2022-0033] [Reference Citation Analysis]
6 Esmaeilzadeh A, Maleki AJ, Moradi A, Siahmansouri A, Yavari MJ, Karami P, Elahi R. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks. Expert Review of Vaccines. [DOI: 10.1080/14760584.2022.2116008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Stoll SE, Werner P, Wetsch WA, Dusse F, Bunck AC, Kochanek M, Popp F, Schmidt T, Bruns C, Böttiger BW. Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report. J Med Case Rep 2022;16:271. [PMID: 35821156 DOI: 10.1186/s13256-022-03464-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vizcaíno-carruyo JC, Toro-montoya AI. Alteraciones hematológicas como consecuencia de COVID-19 y sus vacunas. Med Lab 2022;26:219-236. [DOI: 10.36384/01232576.587] [Reference Citation Analysis]
9 Kurup D, Wirblich C, Zabihi Diba L, Lambert R, Watson M, Shaikh N, Ramage H, Solomides C, Schnell MJ. A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model. Viruses 2022;14:1126. [DOI: 10.3390/v14061126] [Reference Citation Analysis]
10 Ribeiro MI, Pimenta I, Conde I, Gonzalez FA. Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination. BMJ Case Rep 2022;15:e247346. [PMID: 35589271 DOI: 10.1136/bcr-2021-247346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kurup D, Wirblich C, Diba LZ, Lambert R, Watson M, Shaikh N, Ramage H, Solomides C, Schnell MJ. A single-dose of the deactivated rabies virus vectored COVID-19 vaccine, CORAVAX, is highly efficacious and alleviates lung inflammation in the hamster model.. [DOI: 10.1101/2022.02.21.481324] [Reference Citation Analysis]
12 Simnani FZ, Singh D, Kaur R. COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review. 3 Biotech 2022;12:15. [PMID: 34926119 DOI: 10.1007/s13205-021-03076-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
13 Kheyrandish S, Rastgar A, Arab-zozani M, Sarab GA. Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies. Front Med 2021;8. [DOI: 10.3389/fmed.2021.794599] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
14 Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Afsharian M, Saleki K, Barary M, Ebrahimpour S. Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients. Rev Med Virol 2021;:e2273. [PMID: 34197678 DOI: 10.1002/rmv.2273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]